{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,8]],"date-time":"2026-11-08T00:56:26Z","timestamp":1794099386988,"version":"4.8.0"},"reference-count":211,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,12,9]],"date-time":"2025-12-09T00:00:00Z","timestamp":1765238400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,1,13]],"date-time":"2026-01-13T00:00:00Z","timestamp":1768262400000},"content-version":"vor","delay-in-days":35,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100018542","name":"Natural Science Foundation of Sichuan Province","doi-asserted-by":"publisher","award":["2024NSFSC2123"],"award-info":[{"award-number":["2024NSFSC2123"]}],"id":[{"id":"10.13039\/501100018542","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002858","name":"China Postdoctoral Science Foundation","doi-asserted-by":"publisher","award":["2025M771949"],"award-info":[{"award-number":["2025M771949"]}],"id":[{"id":"10.13039\/501100002858","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Sichuan Science and Technology Program","award":["2025ZNSFSC1646"],"award-info":[{"award-number":["2025ZNSFSC1646"]}]},{"DOI":"10.13039\/100007404","name":"Clinical Trial Center, China Medical University Hospital","doi-asserted-by":"publisher","award":["2024HXBH065"],"award-info":[{"award-number":["2024HXBH065"]}],"id":[{"id":"10.13039\/100007404","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Transl Med"],"DOI":"10.1186\/s12967-025-07506-y","type":"journal-article","created":{"date-parts":[[2025,12,9]],"date-time":"2025-12-09T04:16:59Z","timestamp":1765253819000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Myalgic encephalomyelitis\/chronic fatigue syndrome (ME\/CFS): diagnosis and management"],"prefix":"10.1186","volume":"24","author":[{"given":"Jin","family":"Fan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiao","family":"Jiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hai-Qing","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dong-Ling","family":"Zhong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao-Bo","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ling-Min","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rong-Jiang","family":"Jin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xi","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,12,9]]},"reference":[{"issue":"3","key":"7506_CR1","doi-asserted-by":"publisher","first-page":"91","DOI":"10.3390\/diagnostics9030091","volume":"9","author":"M Cortes Rivera","year":"2019","unstructured":"Cortes Rivera M, Mastronardi C, Silva-Aldana CT, Arcos-Burgos M, Lidbury BA. Myalgic Encephalomyelitis\/Chronic fatigue syndrome: A comprehensive review. Diagnostics (Basel). 2019;9(3):91.","journal-title":"Diagnostics (Basel)"},{"key":"7506_CR2","doi-asserted-by":"crossref","unstructured":"Bateman L, Bested AC, Bonilla HF, Chheda BV, Chu L, Curtin JM, et al. Myalgic encephalomyelitis\/chronic fatigue syndrome: essentials of diagnosis and management. Mayo Clin Proc. 2021;96(11):2861-78.","DOI":"10.1016\/j.mayocp.2021.07.004"},{"issue":"10","key":"7506_CR3","first-page":"e70616","volume":"16","author":"BS Graves","year":"2024","unstructured":"Graves BS, Patel M, Newgent H, Parvathy G, Nasri A, Moxam J, et al. Chronic fatigue syndrome: Diagnosis, Treatment, and future direction. Cureus. 2024;16(10):e70616.","journal-title":"Cureus"},{"key":"7506_CR4","doi-asserted-by":"publisher","first-page":"1460157","DOI":"10.3389\/fnins.2024.1460157","volume":"18","author":"G Lange","year":"2024","unstructured":"Lange G, Lin JS, Chen Y, Fall EA, Peterson DL, Bateman L, et al. Cognitive assessment in myalgic encephalomyelitis\/chronic fatigue syndrome (ME\/CFS): a cognitive substudy of the multi-site clinical assessment of ME\/CFS (MCAM). Front Neurosci. 2024;18:1460157.","journal-title":"Front Neurosci"},{"issue":"7","key":"7506_CR5","doi-asserted-by":"publisher","first-page":"1868","DOI":"10.1038\/s44321-025-00258-8","volume":"17","author":"S Beentjes","year":"2025","unstructured":"Beentjes S, Kaczmarczyk J, Cassar A, Samms G, Hejazi N, Khamseh A, et al. Replicated blood-based biomarkers for myalgic encephalomyelitis not explicable by inactivity. EMBO Mol Med. 2025;17(7):1868\u201391.","journal-title":"EMBO Mol Med"},{"issue":"1","key":"7506_CR6","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1186\/s12967-022-03764-2","volume":"20","author":"N Azcue","year":"2022","unstructured":"Azcue N, G\u00f3mez-Esteban JC, Acera M, Tijero B, Fernandez T, Ayo-Mentxakatorre N, et al. Brain fog of post-COVID-19 condition and chronic fatigue Syndrome, same medical disorder? J Transl Med. 2022;20(1):569.","journal-title":"J Transl Med"},{"key":"7506_CR7","doi-asserted-by":"publisher","first-page":"101019","DOI":"10.1016\/j.eclinm.2021.101019","volume":"38","author":"HE Davis","year":"2021","unstructured":"Davis HE, Assaf GS, McCorkell L, Wei H, Low RJ, Re\u2019em Y, et al. Characterizing long COVID in an international cohort: 7 months of symptoms and their impact. EClinicalMedicine. 2021;38:101019.","journal-title":"EClinicalMedicine"},{"issue":"1","key":"7506_CR8","doi-asserted-by":"publisher","first-page":"6571","DOI":"10.1038\/s41467-021-26513-3","volume":"12","author":"Y Xie","year":"2021","unstructured":"Xie Y, Bowe B, Al-Aly Z. Burdens of post-acute sequelae of COVID-19 by severity of acute infection, demographics and health status. Nat Commun. 2021;12(1):6571.","journal-title":"Nat Commun"},{"key":"7506_CR9","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/j.bbi.2021.12.020","volume":"101","author":"F Ceban","year":"2022","unstructured":"Ceban F, Ling S, Lui LMW, Lee Y, Gill H, Teopiz KM, et al. Fatigue and cognitive impairment in Post-COVID-19 syndrome: A systematic review and meta-analysis. Brain Behav Immun. 2022;101:93\u2013135.","journal-title":"Brain Behav Immun"},{"issue":"9","key":"7506_CR10","doi-asserted-by":"publisher","first-page":"895","DOI":"10.1016\/j.molmed.2021.06.002","volume":"27","author":"AL Komaroff","year":"2021","unstructured":"Komaroff AL, Lipkin WI. Insights from myalgic encephalomyelitis\/chronic fatigue syndrome May help unravel the pathogenesis of postacute COVID-19 syndrome. Trends Mol Med. 2021;27(9):895\u2013906.","journal-title":"Trends Mol Med"},{"issue":"1","key":"7506_CR11","doi-asserted-by":"publisher","first-page":"5104","DOI":"10.1038\/s41467-022-32507-6","volume":"13","author":"C Kedor","year":"2022","unstructured":"Kedor C, Freitag H, Meyer-Arndt L, Wittke K, Hanitsch LG, Zoller T, et al. A prospective observational study of post-COVID-19 chronic fatigue syndrome following the first pandemic wave in Germany and biomarkers associated with symptom severity. Nat Commun. 2022;13(1):5104.","journal-title":"Nat Commun"},{"issue":"1","key":"7506_CR12","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1186\/s12967-020-02269-0","volume":"18","author":"EJ Lim","year":"2020","unstructured":"Lim EJ, Ahn YC, Jang ES, Lee SW, Lee SH, Son CG. Systematic review and meta-analysis of the prevalence of chronic fatigue syndrome\/myalgic encephalomyelitis (CFS\/ME). J Transl Med. 2020;18(1):100.","journal-title":"J Transl Med"},{"key":"7506_CR13","doi-asserted-by":"crossref","unstructured":"Vahratian A, Lin JS, Bertolli J, Unger ER. Myalgic encephalomyelitis\/chronic fatigue syndrome in adults: United States, 2021\u20132022. NCHS Data Brief. 2023(488):1\u20138.","DOI":"10.15620\/cdc:134504"},{"key":"7506_CR14","doi-asserted-by":"crossref","unstructured":"Ziauddeen N, Gurdasani D, O\u2019Hara ME, Hastie C, Roderick P, Yao G, et al. Characteristics of long covid: Findings from an online survey. PLoS One. 2022;17(3):e0264331.","DOI":"10.1371\/journal.pone.0264331"},{"issue":"3","key":"7506_CR15","first-page":"208","volume":"57","author":"J Cullinan","year":"2021","unstructured":"Cullinan J, Pheby DFH, Araja D, Berkis U, Brenna E, de Korwin JD, et al. Perceptions of European ME\/CFS experts concerning knowledge and Understanding of ME\/CFS among primary care physicians in europe: A report from the European ME\/CFS research network (EUROMENE). Med (Kaunas). 2021;57(3):208.","journal-title":"Med (Kaunas)"},{"key":"7506_CR16","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1186\/s41073-019-0064-8","volume":"4","author":"C Baethge","year":"2019","unstructured":"Baethge C, Goldbeck-Wood S, Mertens S. SANRA-a scale for the quality assessment of narrative review articles. Res Integr Peer Rev. 2019;4:5.","journal-title":"Res Integr Peer Rev"},{"issue":"3","key":"7506_CR17","doi-asserted-by":"publisher","first-page":"387","DOI":"10.7326\/0003-4819-108-3-387","volume":"108","author":"GP Holmes","year":"1988","unstructured":"Holmes GP, Kaplan JE, Gantz NM, Komaroff AL, Schonberger LB, Straus SE, et al. Chronic fatigue syndrome: a working case definition. Ann Intern Med. 1988;108(3):387\u20139.","journal-title":"Ann Intern Med"},{"issue":"2","key":"7506_CR18","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1177\/014107689108400224","volume":"84","author":"MC Sharpe","year":"1991","unstructured":"Sharpe MC, Archard LC, Banatvala JE, Borysiewicz LK, Clare AW, David A, et al. A report\u2013chronic fatigue syndrome: guidelines for research. J R Soc Med. 1991;84(2):118\u201321.","journal-title":"J R Soc Med"},{"issue":"12","key":"7506_CR19","doi-asserted-by":"publisher","first-page":"953","DOI":"10.7326\/0003-4819-121-12-199412150-00009","volume":"121","author":"K Fukuda","year":"1994","unstructured":"Fukuda K, Straus SE, Hickie I, Sharpe MC, Dobbins JG, Komaroff A. The chronic fatigue syndrome: a comprehensive approach to its definition and study. International chronic fatigue syndrome study group. Ann Intern Med. 1994;121(12):953\u20139.","journal-title":"Ann Intern Med"},{"issue":"1","key":"7506_CR20","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1300\/J092v11n01_02","volume":"11","author":"BM Carruthers","year":"2003","unstructured":"Carruthers BM, Jain AK, de Meirleir KL, Peterson DL, Klimas NG, Lerner AM, et al. Myalgic Encephalomyelitis\/Chronic fatigue syndrome: clinical working case Definition, diagnostic and treatment protocols. J Chronic Fatigue Syndrome. 2003;11(1):7\u2013115.","journal-title":"J Chronic Fatigue Syndrome"},{"key":"7506_CR21","volume-title":"Chronic fatigue Syndrome\/Myalgic encephalomyelitis (or Encephalopathy): diagnosis and management of chronic fatigue Syndrome\/Myalgic encephalomyelitis (or Encephalopathy) in adults and children [Internet]","author":"National Collaborating Centre for Primary (UK)","year":"2007","unstructured":"National Collaborating Centre for Primary (UK). Chronic fatigue Syndrome\/Myalgic encephalomyelitis (or Encephalopathy): diagnosis and management of chronic fatigue Syndrome\/Myalgic encephalomyelitis (or Encephalopathy) in adults and children [Internet]. London: Royal College of General Practitioners (UK); 2007."},{"issue":"11","key":"7506_CR22","doi-asserted-by":"publisher","first-page":"1101","DOI":"10.1001\/jama.2015.1346","volume":"313","author":"EW Clayton","year":"2015","unstructured":"Clayton EW. Beyond myalgic encephalomyelitis\/chronic fatigue syndrome: an IOM report on redefining an illness. JAMA. 2015;313(11):1101\u20132.","journal-title":"JAMA"},{"key":"7506_CR23","doi-asserted-by":"publisher","first-page":"928945","DOI":"10.3389\/fimmu.2022.928945","volume":"13","author":"S Gravelsina","year":"2022","unstructured":"Gravelsina S, Vilmane A, Svirskis S, Rasa-Dzelzkaleja S, Nora-Krukle Z, Vecvagare K, et al. Biomarkers in the diagnostic algorithm of myalgic encephalomyelitis\/chronic fatigue syndrome. Front Immunol. 2022;13:928945.","journal-title":"Front Immunol"},{"issue":"8","key":"7506_CR24","first-page":"1370","volume":"60","author":"R Kaur","year":"2024","unstructured":"Kaur R, Greeley B, Ciok A, Mehta K, Tsai M, Robertson H, et al. A multimodal magnetic resonance imaging study on myalgic Encephalomyelitis\/Chronic fatigue syndrome: feasibility and clinical correlation. Med (Kaunas). 2024;60(8):1370.","journal-title":"Med (Kaunas)"},{"issue":"1","key":"7506_CR25","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1038\/s43856-024-00669-7","volume":"4","author":"K Huang","year":"2024","unstructured":"Huang K, A GCdS, Thomas N, Phair RD, Gooley PR, Ascher DB, et al. Discriminating myalgic Encephalomyelitis\/Chronic fatigue syndrome and comorbid conditions using metabolomics in UK biobank. Commun Med (Lond). 2024;4(1):248.","journal-title":"Commun Med (Lond)"},{"issue":"7","key":"7506_CR26","doi-asserted-by":"publisher","first-page":"1539","DOI":"10.3390\/biomedicines12071539","volume":"12","author":"N Azcue","year":"2024","unstructured":"Azcue N, Tijero-Merino B, Acera M, P\u00e9rez-Garay R, Fern\u00e1ndez-Valle T, Ayo-Mentxakatorre N, et al. Plasma neurofilament light chain: A potential biomarker for neurological dysfunction in myalgic Encephalomyelitis\/Chronic fatigue syndrome. Biomedicines. 2024;12(7):1539.","journal-title":"Biomedicines"},{"issue":"21","key":"7506_CR27","doi-asserted-by":"publisher","first-page":"10250","DOI":"10.1073\/pnas.1901274116","volume":"116","author":"R Esfandyarpour","year":"2019","unstructured":"Esfandyarpour R, Kashi A, Nemat-Gorgani M, Wilhelmy J, Davis RW. A nanoelectronics-blood-based diagnostic biomarker for myalgic encephalomyelitis\/chronic fatigue syndrome (ME\/CFS). Proc Natl Acad Sci U S A. 2019;116(21):10250\u20137.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1","key":"7506_CR28","doi-asserted-by":"publisher","first-page":"34","DOI":"10.3390\/metabo10010034","volume":"10","author":"A Germain","year":"2020","unstructured":"Germain A, Barupal DK, Levine SM, Hanson MR. Comprehensive circulatory metabolomics in ME\/CFS reveals disrupted metabolism of acyl lipids and steroids. Metabolites. 2020;10(1):34.","journal-title":"Metabolites"},{"key":"7506_CR29","doi-asserted-by":"publisher","first-page":"2","DOI":"10.3389\/fncom.2020.00002","volume":"14","author":"D Provenzano","year":"2020","unstructured":"Provenzano D, Washington SD, Baraniuk JN. A machine learning approach to the differentiation of functional magnetic resonance imaging data of chronic fatigue syndrome (CFS) from a sedentary control. Front Comput Neurosci. 2020;14:2.","journal-title":"Front Comput Neurosci"},{"issue":"6","key":"7506_CR30","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1016\/j.autrev.2018.01.009","volume":"17","author":"F Sotzny","year":"2018","unstructured":"Sotzny F, Blanco J, Capelli E, Castro-Marrero J, Steiner S, Murovska M, et al. Myalgic Encephalomyelitis\/Chronic fatigue Syndrome - Evidence for an autoimmune disease. Autoimmun Rev. 2018;17(6):601\u20139.","journal-title":"Autoimmun Rev"},{"issue":"1","key":"7506_CR31","doi-asserted-by":"publisher","first-page":"101373","DOI":"10.1016\/j.xcrm.2023.101373","volume":"5","author":"LT Vu","year":"2024","unstructured":"Vu LT, Ahmed F, Zhu H, Iu DSH, Fogarty EA, Kwak Y, et al. Single-cell transcriptomics of the immune system in ME\/CFS at baseline and following symptom provocation. Cell Rep Med. 2024;5(1):101373.","journal-title":"Cell Rep Med"},{"key":"7506_CR32","doi-asserted-by":"publisher","first-page":"877772","DOI":"10.3389\/fneur.2022.877772","volume":"13","author":"W Tate","year":"2022","unstructured":"Tate W, Walker M, Sweetman E, Helliwell A, Peppercorn K, Edgar C, et al. Molecular mechanisms of neuroinflammation in ME\/CFS and long COVID to sustain disease and promote relapses. Front Neurol. 2022;13:877772.","journal-title":"Front Neurol"},{"issue":"18","key":"7506_CR33","doi-asserted-by":"publisher","first-page":"1420","DOI":"10.1089\/ars.2020.8230","volume":"34","author":"JC Domingo","year":"2021","unstructured":"Domingo JC, Cordobilla B, Ferrer R, Giralt M, Alegre-Martin J, Castro-Marrero J. Are Circulating fibroblast growth factor 21 and N-Terminal prohormone of brain natriuretic peptide promising novel biomarkers in myalgic Encephalomyelitis\/Chronic fatigue syndrome? Antioxid Redox Signal. 2021;34(18):1420\u20137.","journal-title":"Antioxid Redox Signal"},{"issue":"3","key":"7506_CR34","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1177\/17423953221101606","volume":"19","author":"LA Jason","year":"2023","unstructured":"Jason LA, Gaglio CL, Furst J, Islam M, Sorenson M, Conroy KE, et al. Cytokine network analysis in a community-based pediatric sample of patients with myalgic encephalomyelitis\/chronic fatigue syndrome. Chronic Illn. 2023;19(3):571\u201380.","journal-title":"Chronic Illn"},{"issue":"6","key":"7506_CR35","doi-asserted-by":"publisher","first-page":"1455","DOI":"10.1016\/S1734-1140(12)70943-X","volume":"64","author":"A Gadek-Michalska","year":"2012","unstructured":"Gadek-Michalska A, Tadeusz J, Rachwalska P, Spyrka J, Bugajski J. Brain nitric oxide synthases in the interleukin-1beta-induced activation of hypothalamic-pituitary-adrenal axis. Pharmacol Rep. 2012;64(6):1455\u201365.","journal-title":"Pharmacol Rep"},{"issue":"1","key":"7506_CR36","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1186\/s12974-017-0796-7","volume":"14","author":"ME Roerink","year":"2017","unstructured":"Roerink ME, van der Schaaf ME, Dinarello CA, Knoop H, van der Meer JW. Interleukin-1 as a mediator of fatigue in disease: a narrative review. J Neuroinflammation. 2017;14(1):16.","journal-title":"J Neuroinflammation"},{"key":"7506_CR37","doi-asserted-by":"publisher","first-page":"104578","DOI":"10.1016\/j.psyneuen.2019.104578","volume":"113","author":"MA Jonsjo","year":"2020","unstructured":"Jonsjo MA, Olsson GL, Wicksell RK, Alving K, Holmstrom L, Andreasson A. The role of low-grade inflammation in ME\/CFS (Myalgic Encephalomyelitis\/Chronic fatigue Syndrome) - associations with symptoms. Psychoneuroendocrinology. 2020;113:104578.","journal-title":"Psychoneuroendocrinology"},{"issue":"S1","key":"7506_CR38","first-page":"1","volume":"34","author":"C Kennedy","year":"2020","unstructured":"Kennedy C, Gilkeson J. Effects of TNF-Alpha on TGF-Beta expression in human skeletal muscle cells: A cell model for inflammation. FASEB J. 2020;34(S1):1\u20131.","journal-title":"FASEB J"},{"issue":"S1","key":"7506_CR39","doi-asserted-by":"publisher","first-page":"105534","DOI":"10.1096\/fasebj.29.1_supplement.1055.34","volume":"29","author":"K Earl","year":"2015","unstructured":"Earl K, Sakellariou G, Owens D, Sinclair M, Fenech M, Close G, et al. The role of cytokines in muscle fatigue in patients with chronic fatigue syndrome (CFS). FASEB J. 2015;29:1055.34.","journal-title":"FASEB J"},{"issue":"3","key":"7506_CR40","doi-asserted-by":"publisher","first-page":"e185","DOI":"10.1016\/j.jpainsymman.2023.11.004","volume":"67","author":"J Jiao","year":"2024","unstructured":"Jiao J, Fan J, Zhang Y, Chen L. Efficacy and safety of ketamine to treat cancer pain in adult patients: A systematic review. J Pain Symptom Manage. 2024;67(3):e185\u2013210.","journal-title":"J Pain Symptom Manage"},{"key":"7506_CR41","doi-asserted-by":"publisher","first-page":"1069439","DOI":"10.3389\/fnagi.2023.1069439","volume":"15","author":"S Leonardo","year":"2023","unstructured":"Leonardo S, Fregni F. Association of inflammation and cognition in the elderly: A systematic review and meta-analysis. Front Aging Neurosci. 2023;15:1069439.","journal-title":"Front Aging Neurosci"},{"issue":"6","key":"7506_CR42","doi-asserted-by":"publisher","first-page":"100663","DOI":"10.1016\/j.xcrm.2022.100663","volume":"3","author":"C Schulthei\u00df","year":"2022","unstructured":"Schulthei\u00df C, Willscher E, Paschold L, Gottschick C, Klee B, Henkes SS, et al. The IL-1\u03b2, IL-6, and TNF cytokine triad is associated with post-acute sequelae of COVID-19. Cell Rep Med. 2022;3(6):100663.","journal-title":"Cell Rep Med"},{"key":"7506_CR43","doi-asserted-by":"publisher","first-page":"851835","DOI":"10.3389\/fmicb.2022.851835","volume":"13","author":"E Martynova","year":"2022","unstructured":"Martynova E, Rizvanov A, Urbanowicz RA, Khaiboullina S. Inflammasome contribution to the activation of Th1, Th2, and Th17 immune responses. Front Microbiol. 2022;13:851835.","journal-title":"Front Microbiol"},{"issue":"49","key":"7506_CR44","doi-asserted-by":"publisher","first-page":"eaaw2262","DOI":"10.1126\/sciimmunol.aaw2262","volume":"5","author":"SN Harbour","year":"2020","unstructured":"Harbour SN, DiToro DF, Witte SJ, Zindl CL, Gao M, Schoeb TR, et al. Th17 cells require ongoing classic IL-6 receptor signaling to retain transcriptional and functional identity. Sci Immunol. 2020;5(49):eaaw2262.","journal-title":"Sci Immunol"},{"key":"7506_CR45","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1016\/j.molimm.2018.12.024","volume":"107","author":"J Deng","year":"2019","unstructured":"Deng J, Yu XQ, Wang PH. Inflammasome activation and Th17 responses. Mol Immunol. 2019;107:142\u201364.","journal-title":"Mol Immunol"},{"issue":"7","key":"7506_CR46","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1038\/ni.2059","volume":"12","author":"V Lazarevic","year":"2011","unstructured":"Lazarevic V, Glimcher LH. T-bet in disease. Nat Immunol. 2011;12(7):597\u2013606.","journal-title":"Nat Immunol"},{"issue":"4","key":"7506_CR47","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1111\/neup.12653","volume":"40","author":"QQ Yang","year":"2020","unstructured":"Yang QQ, Li HN, Zhang ST, Yu YL, Wei W, Zhang X, et al. Red nucleus IL-6 mediates the maintenance of neuropathic pain by inducing the productions of TNF-\u03b1 and IL-1\u03b2 through the JAK2\/STAT3 and ERK signaling pathways. Neuropathology. 2020;40(4):347\u201357.","journal-title":"Neuropathology"},{"issue":"1\u20134","key":"7506_CR48","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1016\/j.bbrc.2018.11.021","volume":"507","author":"MT Rahman","year":"2018","unstructured":"Rahman MT, Ghosh C, Hossain M, Linfield D, Rezaee F, Janigro D, et al. IFN-\u03b3, IL-17A, or Zonulin rapidly increase the permeability of the blood-brain and small intestinal epithelial barriers: relevance for neuro-inflammatory diseases. Biochem Biophys Res Commun. 2018;507(1\u20134):274\u20139.","journal-title":"Biochem Biophys Res Commun"},{"issue":"9","key":"7506_CR49","doi-asserted-by":"publisher","first-page":"843","DOI":"10.1038\/icb.2017.56","volume":"95","author":"SA Sonar","year":"2017","unstructured":"Sonar SA, Shaikh S, Joshi N, Atre AN, Lal G. IFN-gamma promotes transendothelial migration of CD4(+) T cells across the blood-brain barrier. Immunol Cell Biol. 2017;95(9):843\u201353.","journal-title":"Immunol Cell Biol"},{"key":"7506_CR50","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1186\/1479-5876-7-96","volume":"7","author":"MA Fletcher","year":"2009","unstructured":"Fletcher MA, Zeng XR, Barnes Z, Levis S, Klimas NG. Plasma cytokines in women with chronic fatigue syndrome. J Transl Med. 2009;7:96.","journal-title":"J Transl Med"},{"issue":"1","key":"7506_CR51","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1016\/j.psychres.2005.01.002","volume":"134","author":"A Tomoda","year":"2005","unstructured":"Tomoda A, Joudoi T, Rabab el M, Matsumoto T, Park TH, Miike T. Cytokine production and modulation: comparison of patients with chronic fatigue syndrome and normal controls. Psychiatry Res. 2005;134(1):101\u20134.","journal-title":"Psychiatry Res"},{"key":"7506_CR52","doi-asserted-by":"publisher","first-page":"796","DOI":"10.3389\/fimmu.2019.00796","volume":"10","author":"JM Cliff","year":"2019","unstructured":"Cliff JM, King EC, Lee JS, Sepulveda N, Wolf AS, Kingdon C, et al. Cellular immune function in myalgic Encephalomyelitis\/Chronic fatigue syndrome (ME\/CFS). Front Immunol. 2019;10:796.","journal-title":"Front Immunol"},{"issue":"15","key":"7506_CR53","doi-asserted-by":"publisher","first-page":"11937","DOI":"10.3390\/ijms241511937","volume":"24","author":"J Maya","year":"2023","unstructured":"Maya J. Surveying the metabolic and dysfunctional profiles of T cells and NK cells in myalgic Encephalomyelitis\/Chronic fatigue syndrome. Int J Mol Sci. 2023;24(15):11937.","journal-title":"Int J Mol Sci"},{"issue":"2","key":"7506_CR54","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1111\/j.1365-2249.2004.02354.x","volume":"135","author":"A Skowera","year":"2004","unstructured":"Skowera A, Cleare A, Blair D, Bevis L, Wessely SC, Peakman M. High levels of type 2 cytokine-producing cells in chronic fatigue syndrome. Clin Exp Immunol. 2004;135(2):294\u2013302.","journal-title":"Clin Exp Immunol"},{"key":"7506_CR55","doi-asserted-by":"publisher","first-page":"30","DOI":"10.12703\/r\/10-30","volume":"10","author":"MJ Butcher","year":"2021","unstructured":"Butcher MJ, Zhu J. Recent advances in Understanding the Th1\/Th2 effector choice. Fac Rev. 2021;10:30.","journal-title":"Fac Rev"},{"key":"7506_CR56","doi-asserted-by":"publisher","first-page":"1369295","DOI":"10.3389\/fimmu.2024.1369295","volume":"15","author":"F Jahanbani","year":"2024","unstructured":"Jahanbani F, Sing JC, Maynard RD, Jahanbani S, Dafoe J, Dafoe W, et al. Longitudinal cytokine and multi-modal health data of an extremely severe ME\/CFS patient with HSD reveals insights into immunopathology, and disease severity. Front Immunol. 2024;15:1369295.","journal-title":"Front Immunol"},{"issue":"3","key":"7506_CR57","first-page":"19","volume":"16","author":"S Torres-Harding","year":"2008","unstructured":"Torres-Harding S, Sorenson M, Jason LA, Maher K, Fletcher MA. Evidence for T-helper 2 shift and association with illness parameters in chronic fatigue syndrome (CFS). Bull IACFS ME. 2008;16(3):19\u201333.","journal-title":"Bull IACFS ME"},{"issue":"1","key":"7506_CR58","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1111\/cei.12043","volume":"172","author":"AS Bradley","year":"2013","unstructured":"Bradley AS, Ford B, Bansal AS. Altered functional B cell subset populations in patients with chronic fatigue syndrome compared to healthy controls. Clin Exp Immunol. 2013;172(1):73\u201380.","journal-title":"Clin Exp Immunol"},{"key":"7506_CR59","doi-asserted-by":"publisher","first-page":"1440643","DOI":"10.3389\/fimmu.2024.1440643","volume":"15","author":"JN Baraniuk","year":"2024","unstructured":"Baraniuk JN, Eaton-Fitch N, Marshall-Gradisnik S. Meta-analysis of natural killer cell cytotoxicity in myalgic encephalomyelitis\/chronic fatigue syndrome. Front Immunol. 2024;15:1440643.","journal-title":"Front Immunol"},{"key":"7506_CR60","doi-asserted-by":"publisher","first-page":"101437","DOI":"10.1016\/j.coviro.2024.101437","volume":"68\u201369","author":"D Obraitis","year":"2024","unstructured":"Obraitis D, Li D. Blood Virome research in myalgic encephalomyelitis\/chronic fatigue syndrome: challenges and opportunities. Curr Opin Virol. 2024;68\u201369:101437.","journal-title":"Curr Opin Virol"},{"issue":"2","key":"7506_CR61","doi-asserted-by":"publisher","first-page":"741","DOI":"10.1007\/s12035-013-8553-0","volume":"49","author":"G Morris","year":"2014","unstructured":"Morris G, Berk M, Galecki P, Maes M. The emerging role of autoimmunity in myalgic encephalomyelitis\/chronic fatigue syndrome (ME\/cfs). Mol Neurobiol. 2014;49(2):741\u201356.","journal-title":"Mol Neurobiol"},{"issue":"3","key":"7506_CR62","doi-asserted-by":"publisher","first-page":"1074","DOI":"10.3390\/ijms21031074","volume":"21","author":"D Missailidis","year":"2020","unstructured":"Missailidis D, Annesley SJ, Allan CY, Sanislav O, Lidbury BA, Lewis DP, et al. An isolated complex V inefficiency and dysregulated mitochondrial function in immortalized lymphocytes from ME\/CFS patients. Int J Mol Sci. 2020;21(3):1074.","journal-title":"Int J Mol Sci"},{"issue":"1","key":"7506_CR63","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1186\/s12967-020-02533-3","volume":"18","author":"E Sweetman","year":"2020","unstructured":"Sweetman E, Kleffmann T, Edgar C, de Lange M, Vallings R, Tate W. A SWATH-MS analysis of myalgic Encephalomyelitis\/Chronic fatigue syndrome peripheral blood mononuclear cell proteomes reveals mitochondrial dysfunction. J Transl Med. 2020;18(1):365.","journal-title":"J Transl Med"},{"key":"7506_CR64","doi-asserted-by":"crossref","unstructured":"Shankar V, Wilhelmy J, Curtis EJ, Michael B, Cervantes L, Mallajosyula VA, et al. Oxidative stress is a shared characteristic of ME\/CFS and long COVID. Proc Natl Acad Sci USA. 2025;122(28):e2426564122.","DOI":"10.1101\/2024.05.04.592477"},{"key":"7506_CR65","doi-asserted-by":"publisher","first-page":"103731","DOI":"10.1016\/j.mcn.2022.103731","volume":"120","author":"G Gottschalk","year":"2022","unstructured":"Gottschalk G, Peterson D, Knox K, Maynard M, Whelan RJ, Roy A. Elevated ATG13 in serum of patients with ME\/CFS stimulates oxidative stress response in microglial cells via activation of receptor for advanced glycation end products (RAGE). Mol Cell Neurosci. 2022;120:103731.","journal-title":"Mol Cell Neurosci"},{"key":"7506_CR66","doi-asserted-by":"publisher","first-page":"101674","DOI":"10.1016\/j.redox.2020.101674","volume":"37","author":"D Nolfi-Donegan","year":"2020","unstructured":"Nolfi-Donegan D, Braganza A, Shiva S. Mitochondrial electron transport chain: oxidative phosphorylation, oxidant production, and methods of measurement. Redox Biol. 2020;37:101674.","journal-title":"Redox Biol"},{"key":"7506_CR67","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1016\/j.jare.2024.11.011","volume":"75","author":"AF Almulla","year":"2025","unstructured":"Almulla AF, Maes M, Zhou B, Al-Hakeim HK, Vojdani A. Brain-targeted autoimmunity is strongly associated with long COVID and its chronic fatigue syndrome as well as its affective symptoms. J Adv Res. 2025;75:621\u201333.","journal-title":"J Adv Res"},{"issue":"4","key":"7506_CR68","doi-asserted-by":"publisher","first-page":"462","DOI":"10.1016\/j.exer.2007.06.013","volume":"85","author":"D Yang","year":"2007","unstructured":"Yang D, Elner SG, Bian ZM, Till GO, Petty HR, Elner VM. Pro-inflammatory cytokines increase reactive oxygen species through mitochondria and NADPH oxidase in cultured RPE cells. Exp Eye Res. 2007;85(4):462\u201372.","journal-title":"Exp Eye Res"},{"issue":"4","key":"7506_CR69","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1016\/j.tcb.2015.12.002","volume":"26","author":"H Blaser","year":"2016","unstructured":"Blaser H, Dostert C, Mak TW, Brenner D. TNF and ROS crosstalk in inflammation. Trends Cell Biol. 2016;26(4):249\u201361.","journal-title":"Trends Cell Biol"},{"key":"7506_CR70","doi-asserted-by":"publisher","first-page":"4982324","DOI":"10.1155\/2020\/4982324","volume":"2020","author":"E Zinellu","year":"2020","unstructured":"Zinellu E, Zinellu A, Fois AG, Fois SS, Piras B, Carru C, et al. Reliability and usefulness of different biomarkers of oxidative stress in chronic obstructive pulmonary disease. Oxid Med Cell Longev. 2020;2020:4982324.","journal-title":"Oxid Med Cell Longev"},{"issue":"12","key":"7506_CR71","doi-asserted-by":"publisher","first-page":"10255","DOI":"10.3390\/ijms241210255","volume":"24","author":"J Gamer","year":"2023","unstructured":"Gamer J, Van Booven DJ, Zarnowski O, Arango S, Elias M, Kurian A, et al. Sex-Dependent transcriptional changes in response to stress in patients with myalgic Encephalomyelitis\/Chronic fatigue syndrome: A pilot project. Int J Mol Sci. 2023;24(12):10255.","journal-title":"Int J Mol Sci"},{"issue":"Suppl 1","key":"7506_CR72","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1017\/cts.2023.488","volume":"7","author":"NH Hampilos","year":"2023","unstructured":"Hampilos NH, Germain A, Mao X, Hanson MR, Shungu DC. 474 exploring the genetic contribution to oxidative stress in myalgic Encephalomyelitis\/Chronic fatigue syndrome. J Clin Transl Sci. 2023;7(S1):137\u20138.","journal-title":"J Clin Transl Sci"},{"issue":"1","key":"7506_CR73","doi-asserted-by":"publisher","first-page":"12890","DOI":"10.1038\/s41598-018-31270-3","volume":"8","author":"JS Lee","year":"2018","unstructured":"Lee JS, Kim HG, Lee DS, Son CG. Oxidative stress is a convincing contributor to idiopathic chronic fatigue. Sci Rep. 2018;8(1):12890.","journal-title":"Sci Rep"},{"issue":"3","key":"7506_CR74","doi-asserted-by":"publisher","first-page":"2010","DOI":"10.3390\/ijms24032010","volume":"24","author":"J Maya","year":"2023","unstructured":"Maya J, Leddy SM, Gottschalk CG, Peterson DL, Hanson MR. Altered fatty acid oxidation in lymphocyte populations of myalgic Encephalomyelitis\/Chronic fatigue syndrome. Int J Mol Sci. 2023;24(3):2010.","journal-title":"Int J Mol Sci"},{"issue":"3","key":"7506_CR75","doi-asserted-by":"publisher","first-page":"1491","DOI":"10.1172\/JCI132185","volume":"130","author":"AH Mandarano","year":"2020","unstructured":"Mandarano AH, Maya J, Giloteaux L, Peterson DL, Maynard M, Gottschalk CG, et al. Myalgic encephalomyelitis\/chronic fatigue syndrome patients exhibit altered T cell metabolism and cytokine associations. J Clin Invest. 2020;130(3):1491\u2013505.","journal-title":"J Clin Invest"},{"issue":"21","key":"7506_CR76","doi-asserted-by":"publisher","first-page":"e89376","DOI":"10.1172\/jci.insight.89376","volume":"1","author":"\u00d8 Fluge","year":"2016","unstructured":"Fluge \u00d8, Mella O, Bruland O, Risa K, Dyrstad SE, Alme K, et al. Metabolic profiling indicates impaired pyruvate dehydrogenase function in myalgic encephalopathy\/chronic fatigue syndrome. JCI Insight. 2016;1(21):e89376.","journal-title":"JCI Insight"},{"issue":"4","key":"7506_CR77","doi-asserted-by":"publisher","first-page":"702","DOI":"10.3390\/microorganisms13040702","volume":"13","author":"LA Jason","year":"2025","unstructured":"Jason LA, Katz BZ. Predisposing and precipitating factors in Epstein-Barr Virus-Caused myalgic Encephalomyelitis\/Chronic fatigue syndrome. Microorganisms. 2025;13(4):702.","journal-title":"Microorganisms"},{"issue":"3","key":"7506_CR78","doi-asserted-by":"publisher","first-page":"422","DOI":"10.3390\/v17030422","volume":"17","author":"U Hannestad","year":"2025","unstructured":"Hannestad U, Allard A, Nilsson K, Ros\u00e9n A. Prevalence of EBV, HHV6, HCMV, HAdV, SARS-CoV-2, and autoantibodies to type I interferon in sputum from myalgic Encephalomyelitis\/Chronic fatigue syndrome patients. Viruses. 2025;17(3):422.","journal-title":"Viruses"},{"issue":"7","key":"7506_CR79","doi-asserted-by":"publisher","first-page":"e18250","DOI":"10.1016\/j.heliyon.2023.e18250","volume":"9","author":"TD Domingues","year":"2023","unstructured":"Domingues TD, Malato J, Grabowska AD, Lee JS, Ameijeiras-Alonso J, Biecek P, et al. Association analysis between symptomology and herpesvirus IgG antibody concentrations in myalgic encephalomyelitis\/chronic fatigue syndrome (ME\/CFS) and multiple sclerosis. Heliyon. 2023;9(7):e18250.","journal-title":"Heliyon"},{"key":"7506_CR80","doi-asserted-by":"crossref","unstructured":"Mena-Palomo I, Martinez V, Perdersen IM, Ariza M. P-1838. The human Herpesvirus dUTPases of EBV and HSV-1 may contribute to neurological disorders by altering the integrity of the blood brain barrier and promoting a pro-inflammatory microenvironment. Open Forum Infect Dis. 2025;12(S1):ofae631.2001.","DOI":"10.1093\/ofid\/ofae631.2001"},{"key":"7506_CR81","doi-asserted-by":"publisher","first-page":"589","DOI":"10.3389\/fpsyt.2018.00589","volume":"9","author":"M Noda","year":"2018","unstructured":"Noda M, Ifuku M, Hossain MS, Katafuchi T. Glial activation and expression of the serotonin transporter in chronic fatigue syndrome. Front Psychiatry. 2018;9:589.","journal-title":"Front Psychiatry"},{"issue":"2","key":"7506_CR82","doi-asserted-by":"publisher","first-page":"150","DOI":"10.3390\/cells13020150","volume":"13","author":"G Schiera","year":"2024","unstructured":"Schiera G, Di Liegro CM, Schir\u00f2 G, Sorbello G, Di Liegro I. Involvement of astrocytes in the Formation, Maintenance, and function of the Blood-Brain barrier. Cells. 2024;13(2):150.","journal-title":"Cells"},{"key":"7506_CR83","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1016\/j.bbi.2024.11.022","volume":"124","author":"L Chen","year":"2025","unstructured":"Chen L, Jiao J, Lei F, Zhou B, Li H, Liao P, et al. Ezrin-mediated astrocyte-synapse signaling regulates cognitive function via astrocyte morphological changes in fine processes in male mice. Brain Behav Immun. 2025;124:177\u201391.","journal-title":"Brain Behav Immun"},{"key":"7506_CR84","doi-asserted-by":"publisher","first-page":"903455","DOI":"10.3389\/fnagi.2022.903455","volume":"14","author":"Y Sun","year":"2022","unstructured":"Sun Y, Koyama Y, Shimada S. Inflammation from peripheral organs to the brain: how does systemic inflammation cause neuroinflammation? Front Aging Neurosci. 2022;14:903455.","journal-title":"Front Aging Neurosci"},{"issue":"10","key":"7506_CR85","doi-asserted-by":"publisher","first-page":"5784","DOI":"10.1111\/ejn.15828","volume":"56","author":"I Tsilioni","year":"2022","unstructured":"Tsilioni I, Natelson B, Theoharides TC. Exosome-associated mitochondrial DNA from patients with myalgic encephalomyelitis\/chronic fatigue syndrome stimulates human microglia to release IL-1\u03b2. Eur J Neurosci. 2022;56(10):5784\u201394.","journal-title":"Eur J Neurosci"},{"issue":"1","key":"7506_CR86","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1007\/s00213-021-05986-6","volume":"239","author":"BR Godlewska","year":"2022","unstructured":"Godlewska BR, Williams S, Emir UE, Chen C, Sharpley AL, Goncalves AJ, et al. Neurochemical abnormalities in chronic fatigue syndrome: a pilot magnetic resonance spectroscopy study at 7 Tesla. Psychopharmacology. 2022;239(1):163\u201371.","journal-title":"Psychopharmacology"},{"issue":"2","key":"7506_CR87","doi-asserted-by":"publisher","first-page":"103484","DOI":"10.1016\/j.autrev.2023.103484","volume":"23","author":"JS Lee","year":"2024","unstructured":"Lee JS, Sato W, Son CG. Brain-regional characteristics and neuroinflammation in ME\/CFS patients from neuroimaging: A systematic review and meta-analysis. Autoimmun Rev. 2024;23(2):103484.","journal-title":"Autoimmun Rev"},{"issue":"10","key":"7506_CR88","doi-asserted-by":"publisher","first-page":"1079","DOI":"10.1038\/s41423-022-00902-0","volume":"19","author":"G Morris","year":"2022","unstructured":"Morris G, Gevezova M, Sarafian V, Maes M. Redox regulation of the immune response. Cell Mol Immunol. 2022;19(10):1079\u2013101.","journal-title":"Cell Mol Immunol"},{"key":"7506_CR89","doi-asserted-by":"publisher","first-page":"1359600","DOI":"10.3389\/fimmu.2024.1359600","volume":"15","author":"RR Manoharan","year":"2024","unstructured":"Manoharan RR, Prasad A, Posp\u00ed\u0161il P, Kzhyshkowska J. ROS signaling in innate immunity via oxidative protein modifications. Front Immunol. 2024;15:1359600.","journal-title":"Front Immunol"},{"key":"7506_CR90","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/j.freeradbiomed.2016.05.014","volume":"97","author":"GS Youn","year":"2016","unstructured":"Youn GS, Lee KW, Choi SY, Park J. Overexpression of HDAC6 induces pro-inflammatory responses by regulating ROS-MAPK-NF-\u03baB\/AP-1 signaling pathways in macrophages. Free Radic Biol Med. 2016;97:14\u201323.","journal-title":"Free Radic Biol Med"},{"issue":"11","key":"7506_CR91","doi-asserted-by":"publisher","first-page":"4398","DOI":"10.21037\/jtd.2017.09.135","volume":"9","author":"J Wang","year":"2017","unstructured":"Wang J, Huang J, Wang L, Chen C, Yang D, Jin M, et al. Urban particulate matter triggers lung inflammation via the ROS-MAPK-NF-\u03baB signaling pathway. J Thorac Dis. 2017;9(11):4398\u2013412.","journal-title":"J Thorac Dis"},{"issue":"2","key":"7506_CR92","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1016\/j.jdermsci.2012.10.009","volume":"69","author":"HH Tsai","year":"2013","unstructured":"Tsai HH, Lee WR, Wang PH, Cheng KT, Chen YC, Shen SC. Propionibacterium acnes-induced iNOS and COX-2 protein expression via ROS-dependent NF-\u03baB and AP-1 activation in macrophages. J Dermatol Sci. 2013;69(2):122\u201331.","journal-title":"J Dermatol Sci"},{"key":"7506_CR93","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1146\/annurev-biophys-083012-130338","volume":"42","author":"J Napetschnig","year":"2013","unstructured":"Napetschnig J, Wu H. Molecular basis of NF-\u03baB signaling. Annu Rev Biophys. 2013;42:443\u201368.","journal-title":"Annu Rev Biophys"},{"key":"7506_CR94","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/j.freeradbiomed.2017.07.013","volume":"112","author":"JG Kim","year":"2017","unstructured":"Kim JG, Choi KC, Hong CW, Park HS, Choi EK, Kim YS, et al. Tyr42 phosphorylation of RhoA GTPase promotes tumorigenesis through nuclear factor (NF)-\u03baB. Free Radic Biol Med. 2017;112:69\u201383.","journal-title":"Free Radic Biol Med"},{"issue":"18","key":"7506_CR95","doi-asserted-by":"publisher","first-page":"1420","DOI":"10.1089\/ars.2020.8230","volume":"34","author":"JC Domingo","year":"2021","unstructured":"Domingo JC, Cordobilla B, Ferrer R, Giralt M, Alegre-Mart\u00edn J, Castro-Marrero J. Are Circulating fibroblast growth factor 21 and N-Terminal prohormone of brain natriuretic peptide promising novel biomarkers in myalgic Encephalomyelitis\/Chronic fatigue syndrome? Antioxid Redox Signal. 2021;34(18):1420\u20137.","journal-title":"Antioxid Redox Signal"},{"issue":"1","key":"7506_CR96","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1248\/bpb.b19-00616","volume":"43","author":"Q He","year":"2020","unstructured":"He Q, Sawada M, Yamasaki N, Akazawa S, Furuta H, Uenishi H, et al. Neuroinflammation, oxidative Stress, and neurogenesis in a mouse model of chronic fatigue Syndrome, and the treatment with Kampo medicine. Biol Pharm Bull. 2020;43(1):110\u20135.","journal-title":"Biol Pharm Bull"},{"issue":"9","key":"7506_CR97","doi-asserted-by":"publisher","first-page":"1081","DOI":"10.1517\/14728222.2013.818657","volume":"17","author":"M Meeus","year":"2013","unstructured":"Meeus M, Nijs J, Hermans L, Goubert D, Calders P. The role of mitochondrial dysfunctions due to oxidative and nitrosative stress in the chronic pain or chronic fatigue syndromes and fibromyalgia patients: peripheral and central mechanisms as therapeutic targets? Expert Opin Ther Targets. 2013;17(9):1081\u20139.","journal-title":"Expert Opin Ther Targets"},{"issue":"1","key":"7506_CR98","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1007\/s11011-013-9435-x","volume":"29","author":"G Morris","year":"2014","unstructured":"Morris G, Maes M. Mitochondrial dysfunctions in myalgic encephalomyelitis\/chronic fatigue syndrome explained by activated immuno-inflammatory, oxidative and nitrosative stress pathways. Metab Brain Dis. 2014;29(1):19\u201336.","journal-title":"Metab Brain Dis"},{"issue":"3","key":"7506_CR99","first-page":"5","volume":"3","author":"BD Mazer","year":"2023","unstructured":"Mazer BD. The use of IVIG for allergy consultants. Can Allergy Immunol Today [Internet]. 2023;3(3):5\u20138.","journal-title":"Can Allergy Immunol Today [Internet]"},{"issue":"1","key":"7506_CR100","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1186\/s13063-024-07982-5","volume":"25","author":"H Pre\u00dfler","year":"2024","unstructured":"Pre\u00dfler H, Machule ML, Ufer F, B\u00fcnger I, Li LY, Buchholz E, et al. IA-PACS-CFS: a double-blinded, randomized, sham-controlled, exploratory trial of immunoadsorption in patients with chronic fatigue syndrome (CFS) including patients with post-acute COVID-19 CFS (PACS-CFS). Trials. 2024;25(1):172.","journal-title":"Trials"},{"issue":"9","key":"7506_CR101","doi-asserted-by":"publisher","first-page":"e100","DOI":"10.1086\/374666","volume":"36","author":"JR Kerr","year":"2003","unstructured":"Kerr JR, Cunniffe VS, Kelleher P, Bernstein RM, Bruce IN. Successful intravenous Immunoglobulin therapy in 3 cases of parvovirus B19-associated chronic fatigue syndrome. Clin Infect Dis. 2003;36(9):e100\u20136.","journal-title":"Clin Infect Dis"},{"issue":"3","key":"7506_CR102","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1007\/s10875-007-9088-9","volume":"27","author":"VS Negi","year":"2007","unstructured":"Negi VS, Elluru S, Sib\u00e9ril S, Graff-Dubois S, Mouthon L, Kazatchkine MD, et al. Intravenous immunoglobulin: an update on the clinical use and mechanisms of action. J Clin Immunol. 2007;27(3):233\u201345.","journal-title":"J Clin Immunol"},{"issue":"7","key":"7506_CR103","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1016\/j.clinthera.2024.05.010","volume":"46","author":"P Sjogren","year":"2024","unstructured":"Sjogren P, Brag\u00e9e B, Britton S. Successful subcutaneous Immunoglobulin therapy in a case series of patients with myalgic Encephalomyelitis\/Chronic fatigue syndrome. Clin Ther. 2024;46(7):597\u2013600.","journal-title":"Clin Ther"},{"issue":"1","key":"7506_CR104","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1016\/S0002-9343(97)90045-0","volume":"103","author":"U Vollmer-Conna","year":"1997","unstructured":"Vollmer-Conna U, Hickie I, Hadzi-Pavlovic D, Tymms K, Wakefield D, Dwyer J, et al. Intravenous Immunoglobulin is ineffective in the treatment of patients with chronic fatigue syndrome. Am J Med. 1997;103(1):38\u201343.","journal-title":"Am J Med"},{"issue":"10","key":"7506_CR105","doi-asserted-by":"publisher","first-page":"e0240403","DOI":"10.1371\/journal.pone.0240403","volume":"15","author":"DR Strayer","year":"2020","unstructured":"Strayer DR, Young D, Mitchell WM. Effect of disease duration in a randomized phase III trial of rintatolimod, an immune modulator for myalgic Encephalomyelitis\/Chronic fatigue syndrome. PLoS ONE. 2020;15(10):e0240403.","journal-title":"PLoS ONE"},{"key":"7506_CR106","doi-asserted-by":"crossref","unstructured":"Strayer DR, Carter WA, Stouch BC, Stevens SR, Bateman L, Cimoch PJ, et al. A double-blind, placebo-controlled, randomized, clinical trial of the TLR-3 agonist rintatolimod in severe cases of chronic fatigue syndrome. PLoS ONE. 2012;7(3):e31334.","DOI":"10.1371\/journal.pone.0031334"},{"key":"7506_CR107","doi-asserted-by":"publisher","first-page":"107916","DOI":"10.1016\/j.pharmthera.2021.107916","volume":"228","author":"B Pedre","year":"2021","unstructured":"Pedre B, Barayeu U, Ezeri\u0146a D, Dick TP. The mechanism of action of N-acetylcysteine (NAC): the emerging role of H(2)S and sulfane sulfur species. Pharmacol Ther. 2021;228:107916.","journal-title":"Pharmacol Ther"},{"key":"7506_CR108","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1016\/j.clnesp.2023.01.021","volume":"54","author":"M Mahmoudinezhad","year":"2023","unstructured":"Mahmoudinezhad M, Abbaszadeh F, Zarezadeh M, Bahreini N, Jamilian P, Jamilian P, et al. N-acetylecysteine, a powerful agent in the reinforcement of anti-oxidant profile: A systematic review and dose-response meta-analysis of controlled clinical trials. Clin Nutr ESPEN. 2023;54:227\u201338.","journal-title":"Clin Nutr ESPEN"},{"issue":"6","key":"7506_CR109","doi-asserted-by":"publisher","first-page":"967","DOI":"10.3390\/antiox10060967","volume":"10","author":"M Ten\u00f3rio","year":"2021","unstructured":"Ten\u00f3rio M, Graciliano NG, Moura FA, Oliveira ACM, Goulart MOF. N-Acetylcysteine (NAC): impacts on human health. Antioxid (Basel). 2021;10(6):967.","journal-title":"Antioxid (Basel)"},{"issue":"8","key":"7506_CR110","first-page":"1202","volume":"19","author":"G Raghu","year":"2021","unstructured":"Raghu G, Berk M, Campochiaro PA, Jaeschke H, Marenzi G, Richeldi L, et al. The multifaceted therapeutic role of N-Acetylcysteine (NAC) in disorders characterized by oxidative stress. Curr Neuropharmacol. 2021;19(8):1202\u201324.","journal-title":"Curr Neuropharmacol"},{"issue":"4","key":"7506_CR111","doi-asserted-by":"publisher","first-page":"e106361","DOI":"10.5812\/iji.106361","volume":"7","author":"MJ Hasan","year":"2020","unstructured":"Hasan MJ. N-acetylcysteine in severe COVID-19: the possible mechanism. Int J Infect. 2020;7(4):e106361.","journal-title":"Int J Infect"},{"issue":"3","key":"7506_CR112","doi-asserted-by":"publisher","first-page":"e372","DOI":"10.1002\/ctm2.372","volume":"11","author":"P Kumar","year":"2021","unstructured":"Kumar P, Liu C, Hsu JW, Chacko S, Minard C, Jahoor F, et al. Glycine and N-acetylcysteine (GlyNAC) supplementation in older adults improves glutathione deficiency, oxidative stress, mitochondrial dysfunction, inflammation, insulin resistance, endothelial dysfunction, genotoxicity, muscle strength, and cognition: results of a pilot clinical trial. Clin Transl Med. 2021;11(3):e372.","journal-title":"Clin Transl Med"},{"key":"7506_CR113","unstructured":"Weiduschat N, Mao X, Vub D, Blate M, Kang G, Mangat HS, et al. N-Acetylcysteine alleviates cortical glutathione deficit and improves symptoms in CFS: an in vivo validation study using proton magnetic resonance spectroscopy. IACFS\/ME Syllabus. 2016:35."},{"issue":"1","key":"7506_CR114","doi-asserted-by":"publisher","first-page":"574","DOI":"10.3390\/ijms25010574","volume":"25","author":"D Mantle","year":"2024","unstructured":"Mantle D, Hargreaves IP, Domingo JC, Castro-Marrero J. Mitochondrial dysfunction and coenzyme Q10 supplementation in Post-Viral fatigue syndrome: an overview. Int J Mol Sci. 2024;25(1):574.","journal-title":"Int J Mol Sci"},{"key":"7506_CR115","doi-asserted-by":"publisher","first-page":"1191290","DOI":"10.3389\/fphar.2023.1191290","volume":"14","author":"S Dabbaghi Varnousfaderani","year":"2023","unstructured":"Dabbaghi Varnousfaderani S, Musazadeh V, Ghalichi F, Kavyani Z, Razmjouei S, Faghfouri AH, et al. Alleviating effects of coenzyme Q10 supplements on biomarkers of inflammation and oxidative stress: results from an umbrella meta-analysis. Front Pharmacol. 2023;14:1191290.","journal-title":"Front Pharmacol"},{"key":"7506_CR116","doi-asserted-by":"publisher","first-page":"936233","DOI":"10.3389\/fphar.2022.936233","volume":"13","author":"Y Zhang","year":"2022","unstructured":"Zhang Y, Huang X, Liu N, Liu M, Sun C, Qi B, et al. Discovering the potential value of coenzyme Q10 in oxidative stress: enlightenment from a synthesis of clinical evidence based on various population. Front Pharmacol. 2022;13:936233.","journal-title":"Front Pharmacol"},{"issue":"9","key":"7506_CR117","doi-asserted-by":"publisher","first-page":"1970","DOI":"10.3390\/jcm10091970","volume":"10","author":"IP Hargreaves","year":"2021","unstructured":"Hargreaves IP. Coenzyme Q10 in mitochondrial and lysosomal disorders. J Clin Med. 2021;10(9):1970.","journal-title":"J Clin Med"},{"key":"7506_CR118","doi-asserted-by":"publisher","first-page":"883251","DOI":"10.3389\/fphar.2022.883251","volume":"13","author":"IC Tsai","year":"2022","unstructured":"Tsai IC, Hsu CW, Chang CH, Tseng PT, Chang KV. Effectiveness of coenzyme Q10 supplementation for reducing fatigue: A systematic review and Meta-Analysis of randomized controlled trials. Front Pharmacol. 2022;13:883251.","journal-title":"Front Pharmacol"},{"issue":"10\u201312","key":"7506_CR119","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1089\/ars.2022.0018","volume":"36","author":"J Castro-Marrero","year":"2022","unstructured":"Castro-Marrero J, Domingo JC, Cordobilla B, Ferrer R, Giralt M, Sanmart\u00edn-Senta\u00f1es R, et al. Does coenzyme Q10 plus selenium supplementation ameliorate clinical outcomes by modulating oxidative stress and inflammation in individuals with myalgic Encephalomyelitis\/Chronic fatigue syndrome? Antioxid Redox Signal. 2022;36(10\u201312):729\u201339.","journal-title":"Antioxid Redox Signal"},{"issue":"8","key":"7506_CR120","doi-asserted-by":"publisher","first-page":"2658","DOI":"10.3390\/nu13082658","volume":"13","author":"J Castro-Marrero","year":"2021","unstructured":"Castro-Marrero J, Segundo MJ, Lacasa M, Martinez-Martinez A, Senta\u00f1es RS, Alegre-Martin J. Effect of dietary coenzyme Q10 plus NADH supplementation on fatigue perception and Health-Related quality of life in individuals with myalgic Encephalomyelitis\/Chronic fatigue syndrome: A Prospective, Randomized, Double-Blind, Placebo-Controlled trial. Nutrients. 2021;13(8):2658.","journal-title":"Nutrients"},{"issue":"6","key":"7506_CR121","doi-asserted-by":"publisher","first-page":"688","DOI":"10.1038\/nm1577","volume":"13","author":"I Ohsawa","year":"2007","unstructured":"Ohsawa I, Ishikawa M, Takahashi K, Watanabe M, Nishimaki K, Yamagata K, et al. Hydrogen acts as a therapeutic antioxidant by selectively reducing cytotoxic oxygen radicals. Nat Med. 2007;13(6):688\u201394.","journal-title":"Nat Med"},{"issue":"9","key":"7506_CR122","doi-asserted-by":"publisher","first-page":"857","DOI":"10.1139\/cjpp-2019-0059","volume":"97","author":"T Mikami","year":"2019","unstructured":"Mikami T, Tano K, Lee H, Lee H, Park J, Ohta F, et al. Drinking hydrogen water enhances endurance and relieves psychometric fatigue: a randomized, double-blind, placebo-controlled study. Can J Physiol Pharmacol. 2019;97(9):857\u201362.","journal-title":"Can J Physiol Pharmacol"},{"key":"7506_CR123","doi-asserted-by":"publisher","first-page":"1094767","DOI":"10.3389\/fnut.2023.1094767","volume":"10","author":"K Zhou","year":"2023","unstructured":"Zhou K, Liu M, Wang Y, Liu H, Manor B, Bao D, et al. Effects of molecular hydrogen supplementation on fatigue and aerobic capacity in healthy adults: A systematic review and meta-analysis. Front Nutr. 2023;10:1094767.","journal-title":"Front Nutr"},{"issue":"1","key":"7506_CR124","first-page":"26","volume":"10","author":"F Friedberg","year":"2022","unstructured":"Friedberg F, Choi D. Hydrogen water as a treatment for myalgic encephalomyelitis\/chronic fatigue syndrome: a pilot randomized trial. Fatigue: Biomed Health Behav. 2022;10(1):26\u201339.","journal-title":"Fatigue: Biomed Health Behav"},{"issue":"2","key":"7506_CR125","doi-asserted-by":"publisher","first-page":"84","DOI":"10.4103\/2045-9912.385441","volume":"14","author":"SI Hirano","year":"2024","unstructured":"Hirano SI, Ichikawa Y, Sato B, Takefuji Y, Satoh F. Successful treatment of myalgic encephalomyelitis\/chronic fatigue syndrome using hydrogen gas: four case reports. Med Gas Res. 2024;14(2):84\u20136.","journal-title":"Med Gas Res"},{"issue":"4","key":"7506_CR126","doi-asserted-by":"publisher","first-page":"e0124648","DOI":"10.1371\/journal.pone.0124648","volume":"10","author":"B Regland","year":"2015","unstructured":"Regland B, Forsmark S, Halaouate L, Matousek M, Peilot B, Zachrisson O, et al. Response to vitamin B12 and folic acid in myalgic encephalomyelitis and fibromyalgia. PLoS ONE. 2015;10(4):e0124648.","journal-title":"PLoS ONE"},{"key":"7506_CR127","doi-asserted-by":"publisher","first-page":"1102","DOI":"10.3389\/fphar.2019.01102","volume":"10","author":"CLM van Campen","year":"2019","unstructured":"van Campen CLM, Riepma K, Visser FC. Open trial of vitamin B12 nasal drops in adults with myalgic Encephalomyelitis\/Chronic fatigue syndrome: comparison of responders and Non-Responders. Front Pharmacol. 2019;10:1102.","journal-title":"Front Pharmacol"},{"issue":"2","key":"7506_CR128","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1016\/j.pain.2013.10.002","volume":"155","author":"F Wepner","year":"2014","unstructured":"Wepner F, Scheuer R, Schuetz-Wieser B, Machacek P, Pieler-Bruha E, Cross HS, et al. Effects of vitamin D on patients with fibromyalgia syndrome: a randomized placebo-controlled trial. Pain. 2014;155(2):261\u20138.","journal-title":"Pain"},{"issue":"3","key":"7506_CR129","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1016\/j.numecd.2014.10.007","volume":"25","author":"MD Witham","year":"2015","unstructured":"Witham MD, Adams F, McSwiggan S, Kennedy G, Kabir G, Belch JJ, et al. Effect of intermittent vitamin D3 on vascular function and symptoms in chronic fatigue syndrome\u2013a randomised controlled trial. Nutr Metab Cardiovasc Dis. 2015;25(3):287\u201394.","journal-title":"Nutr Metab Cardiovasc Dis"},{"issue":"1","key":"7506_CR130","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/j.ejr.2019.05.002","volume":"42","author":"HA Aldaoseri","year":"2020","unstructured":"Aldaoseri HA, Zubairi MB. Vitamin D deficiency and treatment in Iraqi patients with primary fibromyalgia syndrome. Egypt Rheumatologist. 2020;42(1):47\u201350.","journal-title":"Egypt Rheumatologist"},{"key":"7506_CR131","doi-asserted-by":"publisher","first-page":"47","DOI":"10.12659\/MSM.889333","volume":"20","author":"D Maric","year":"2014","unstructured":"Maric D, Brkic S, Tomic S, Novakov Mikic A, Cebovic T, Turkulov V. Multivitamin mineral supplementation in patients with chronic fatigue syndrome. Med Sci Monit. 2014;20:47\u201353.","journal-title":"Med Sci Monit"},{"issue":"21","key":"7506_CR132","doi-asserted-by":"publisher","first-page":"4504","DOI":"10.3390\/nu15214504","volume":"15","author":"M Lacasa","year":"2023","unstructured":"Lacasa M, Alegre-Martin J, Senta\u00f1es RS, Varela-Sende L, Jurek J, Castro-Marrero J. Yeast Beta-Glucan supplementation with multivitamins attenuates cognitive impairments in individuals with myalgic Encephalomyelitis\/Chronic fatigue syndrome: A Randomized, Double-Blind, Placebo-Controlled trial. Nutrients. 2023;15(21):4504.","journal-title":"Nutrients"},{"issue":"4","key":"7506_CR133","doi-asserted-by":"publisher","first-page":"29","DOI":"10.3897\/rrpharmacology.6.57419","volume":"6","author":"A Voronkov","year":"2020","unstructured":"Voronkov A, Pozdnyakov D. Neuroprotective effect of L-Carnitine. Focus on changing mitochondrial function. Res Results Pharmacol. 2020;6(4):29\u201342.","journal-title":"Res Results Pharmacol"},{"issue":"5","key":"7506_CR134","doi-asserted-by":"publisher","first-page":"2717","DOI":"10.3390\/ijms23052717","volume":"23","author":"MA Virmani","year":"2022","unstructured":"Virmani MA, Cirulli M. The role of l-Carnitine in Mitochondria, prevention of metabolic inflexibility and disease initiation. Int J Mol Sci. 2022;23(5):2717.","journal-title":"Int J Mol Sci"},{"issue":"1","key":"7506_CR135","doi-asserted-by":"publisher","first-page":"10056","DOI":"10.1038\/s41598-018-28477-9","volume":"8","author":"D Nagy-Szakal","year":"2018","unstructured":"Nagy-Szakal D, Barupal DK, Lee B, Che X, Williams BL, Kahn EJR, et al. Insights into myalgic encephalomyelitis\/chronic fatigue syndrome phenotypes through comprehensive metabolomics. Sci Rep. 2018;8(1):10056.","journal-title":"Sci Rep"},{"issue":"3","key":"7506_CR136","doi-asserted-by":"publisher","first-page":"475","DOI":"10.3390\/nu17030475","volume":"17","author":"MC Dorczok","year":"2025","unstructured":"Dorczok MC, Mittmann G, Mossaheb N, Schrank B, Bartova L, Neumann M, et al. Dietary supplementation for fatigue symptoms in myalgic Encephalomyelitis\/Chronic fatigue syndrome (ME\/CFS)-A systematic review. Nutrients. 2025;17(3):475.","journal-title":"Nutrients"},{"key":"7506_CR137","doi-asserted-by":"publisher","first-page":"1358404","DOI":"10.3389\/fendo.2024.1358404","volume":"15","author":"T Raij","year":"2024","unstructured":"Raij T, Raij K. Association between fatigue, peripheral serotonin, and L-carnitine in hypothyroidism and in chronic fatigue syndrome. Front Endocrinol (Lausanne). 2024;15:1358404.","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"1","key":"7506_CR138","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1111\/jnc.13545","volume":"137","author":"HM Wilkins","year":"2016","unstructured":"Wilkins HM, Koppel S, Carl SM, Ramanujan S, Weidling I, Michaelis ML, et al. Oxaloacetate enhances neuronal cell bioenergetic fluxes and infrastructure. J Neurochem. 2016;137(1):76\u201387.","journal-title":"J Neurochem"},{"issue":"4","key":"7506_CR139","doi-asserted-by":"publisher","first-page":"2046","DOI":"10.3390\/ijms22042046","volume":"22","author":"D Missailidis","year":"2021","unstructured":"Missailidis D, Sanislav O, Allan CY, Smith PK, Annesley SJ, Fisher PR. Dysregulated provision of oxidisable substrates to the mitochondria in ME\/CFS lymphoblasts. Int J Mol Sci. 2021;22(4):2046.","journal-title":"Int J Mol Sci"},{"issue":"1","key":"7506_CR140","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1186\/s12967-022-03488-3","volume":"20","author":"A Cash","year":"2022","unstructured":"Cash A, Kaufman DL. Oxaloacetate treatment for mental and physical fatigue in myalgic Encephalomyelitis\/Chronic fatigue syndrome (ME\/CFS) and Long-COVID fatigue patients: a non-randomized controlled clinical trial. J Transl Med. 2022;20(1):295.","journal-title":"J Transl Med"},{"key":"7506_CR141","doi-asserted-by":"publisher","first-page":"1483876","DOI":"10.3389\/fneur.2024.1483876","volume":"15","author":"A Cash","year":"2024","unstructured":"Cash A, Vernon SD, Rond C, Bateman L, Abbaszadeh S, Bell J, et al. RESTORE ME: a RCT of oxaloacetate for improving fatigue in patients with myalgic encephalomyelitis\/chronic fatigue syndrome. Front Neurol. 2024;15:1483876.","journal-title":"Front Neurol"},{"issue":"16","key":"7506_CR142","doi-asserted-by":"publisher","first-page":"8610","DOI":"10.3390\/ijms22168610","volume":"22","author":"N \u0160korja Mili\u0107","year":"2021","unstructured":"\u0160korja Mili\u0107 N, Dolinar K, Mi\u0161 K, Matkovi\u010d U, Bizjak M, Pavlin M, et al. Suppression of pyruvate dehydrogenase kinase by Dichloroacetate in cancer and skeletal muscle cells is isoform specific and partially independent of HIF-1\u03b1. Int J Mol Sci. 2021;22(16):8610.","journal-title":"Int J Mol Sci"},{"key":"7506_CR143","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/j.mehy.2018.03.002","volume":"114","author":"F Comhaire","year":"2018","unstructured":"Comhaire F. Treating patients suffering from myalgic encephalopathy\/chronic fatigue syndrome (ME\/CFS) with sodium dichloroacetate: an open-label, proof-of-principle pilot trial. Med Hypotheses. 2018;114:45\u20138.","journal-title":"Med Hypotheses"},{"key":"7506_CR144","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/j.mehy.2018.08.014","volume":"120","author":"F Comhaire","year":"2018","unstructured":"Comhaire F. Why do some ME\/CFS patients benefit from treatment with sodium dichloroacetate, but others do not? Med Hypotheses. 2018;120:65\u20137.","journal-title":"Med Hypotheses"},{"issue":"7","key":"7506_CR145","doi-asserted-by":"publisher","first-page":"1140","DOI":"10.1248\/bpb.b19-00009","volume":"42","author":"T Ohba","year":"2019","unstructured":"Ohba T, Domoto S, Tanaka M, Nakamura S, Shimazawa M, Hara H. Myalgic Encephalomyelitis\/Chronic fatigue syndrome induced by repeated forced swimming in mice. Biol Pharm Bull. 2019;42(7):1140\u20135.","journal-title":"Biol Pharm Bull"},{"key":"7506_CR146","doi-asserted-by":"publisher","first-page":"687806","DOI":"10.3389\/fimmu.2021.687806","volume":"12","author":"H Cabanas","year":"2021","unstructured":"Cabanas H, Muraki K, Eaton-Fitch N, Staines DR, Marshall-Gradisnik S. Potential therapeutic benefit of low dose Naltrexone in myalgic Encephalomyelitis\/Chronic fatigue syndrome: role of transient receptor potential melastatin 3 ion channels in pathophysiology and treatment. Front Immunol. 2021;12:687806.","journal-title":"Front Immunol"},{"key":"7506_CR147","doi-asserted-by":"publisher","first-page":"2545","DOI":"10.3389\/fimmu.2019.02545","volume":"10","author":"H Cabanas","year":"2019","unstructured":"Cabanas H, Muraki K, Staines D, Marshall-Gradisnik S. Naltrexone restores impaired transient receptor potential melastatin 3 ion channel function in natural killer cells from myalgic Encephalomyelitis\/Chronic fatigue syndrome patients. Front Immunol. 2019;10:2545.","journal-title":"Front Immunol"},{"issue":"1","key":"7506_CR148","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1186\/s12967-022-03297-8","volume":"20","author":"N Eaton-Fitch","year":"2022","unstructured":"Eaton-Fitch N, Du Preez S, Cabanas H, Muraki K, Staines D, Marshall-Gradisnik S. Impaired TRPM3-dependent calcium influx and restoration using Naltrexone in natural killer cells of myalgic encephalomyelitis\/chronic fatigue syndrome patients. J Transl Med. 2022;20(1):94.","journal-title":"J Transl Med"},{"issue":"8","key":"7506_CR149","doi-asserted-by":"publisher","first-page":"9577","DOI":"10.1096\/fj.201900173RRR","volume":"33","author":"X Zhang","year":"2019","unstructured":"Zhang X, Peng Y, Grace PM, Metcalf MD, Kwilasz AJ, Wang Y, et al. Stereochemistry and innate immune recognition: (+)-norbinaltorphimine targets myeloid differentiation protein 2 and inhibits toll-like receptor 4 signaling. FASEB J. 2019;33(8):9577\u201387.","journal-title":"FASEB J"},{"issue":"16","key":"7506_CR150","doi-asserted-by":"publisher","first-page":"8429","DOI":"10.3390\/ijms22168429","volume":"22","author":"N Ku\u010di\u0107","year":"2021","unstructured":"Ku\u010di\u0107 N, Ra\u010dki V, \u0160verko R, Vidovi\u0107 T, Grahovac I, Mr\u0161i\u0107-Pel\u010di\u0107 J. Immunometabolic modulatory role of Naltrexone in BV-2 microglia cells. Int J Mol Sci. 2021;22(16):8429.","journal-title":"Int J Mol Sci"},{"issue":"4","key":"7506_CR151","first-page":"207","volume":"7","author":"O Polo","year":"2019","unstructured":"Polo O, Pesonen P, Tuominen E. Low-dose Naltrexone in the treatment of myalgic encephalomyelitis\/chronic fatigue syndrome (ME\/CFS). Fatigue: Biomed Health Behav. 2019;7(4):207\u201317.","journal-title":"Fatigue: Biomed Health Behav"},{"issue":"11","key":"7506_CR152","doi-asserted-by":"publisher","first-page":"2874","DOI":"10.1021\/acs.bioconjchem.7b00569","volume":"28","author":"R Sharma","year":"2017","unstructured":"Sharma R, Kim SY, Sharma A, Zhang Z, Kambhampati SP, Kannan S, et al. Activated microglia targeting Dendrimer-Minocycline conjugate as therapeutics for neuroinflammation. Bioconjug Chem. 2017;28(11):2874\u201386.","journal-title":"Bioconjug Chem"},{"issue":"16","key":"7506_CR153","doi-asserted-by":"publisher","first-page":"2527","DOI":"10.2169\/internalmedicine.7182-21","volume":"60","author":"T Numata","year":"2021","unstructured":"Numata T. Could Minocycline be a magic bullet for the treatment of myalgic Encephalomyelitis\/Chronic fatigue syndrome? Intern Med. 2021;60(16):2527\u20138.","journal-title":"Intern Med"},{"issue":"3","key":"7506_CR154","first-page":"2989","volume":"16","author":"F Zhan","year":"2024","unstructured":"Zhan F, Dong Y, Zhou L, Li X, Zhou Z, Xu G. Minocycline alleviates LPS-induced cognitive dysfunction in mice by inhibiting the NLRP3\/caspase-1 pathway. Aging. 2024;16(3):2989\u20133006.","journal-title":"Aging"},{"issue":"7","key":"7506_CR155","doi-asserted-by":"publisher","first-page":"1064","DOI":"10.1007\/s12031-020-01509-8","volume":"70","author":"K Afshary","year":"2020","unstructured":"Afshary K, Chamanara M, Talari B, Rezaei P, Nassireslami E. Therapeutic effects of Minocycline pretreatment in the locomotor and sensory complications of spinal cord injury in an animal model. J Mol Neurosci. 2020;70(7):1064\u201372.","journal-title":"J Mol Neurosci"},{"issue":"16","key":"7506_CR156","doi-asserted-by":"publisher","first-page":"2577","DOI":"10.2169\/internalmedicine.6082-20","volume":"60","author":"K Miwa","year":"2021","unstructured":"Miwa K. Oral Minocycline therapy improves symptoms of myalgic Encephalomyelitis, especially in the initial disease stage. Intern Med. 2021;60(16):2577\u201384.","journal-title":"Intern Med"},{"issue":"7","key":"7506_CR157","doi-asserted-by":"publisher","first-page":"4991","DOI":"10.1074\/jbc.M110.169565","volume":"286","author":"S Schildknecht","year":"2011","unstructured":"Schildknecht S, Pape R, M\u00fcller N, Robotta M, Marquardt A, B\u00fcrkle A, et al. Neuroprotection by Minocycline caused by direct and specific scavenging of peroxynitrite. J Biol Chem. 2011;286(7):4991\u20135002.","journal-title":"J Biol Chem"},{"key":"7506_CR158","doi-asserted-by":"publisher","first-page":"100537","DOI":"10.1016\/j.ensci.2024.100537","volume":"38","author":"K Miwa","year":"2025","unstructured":"Miwa K. Oral Minocycline therapy as first-line treatment in patients with myalgic encephalomyelitis and long COVID: A pilot study. eNeurologicalSci. 2025;38:100537.","journal-title":"eNeurologicalSci"},{"key":"7506_CR159","doi-asserted-by":"publisher","first-page":"1495050","DOI":"10.3389\/fnhum.2025.1495050","volume":"19","author":"M Vink","year":"2025","unstructured":"Vink M, Vink-Niese A. CBT and graded exercise therapy studies have proven that ME\/CFS and long COVID are physical diseases, yet no one is aware of that. Front Hum Neurosci. 2025;19:1495050.","journal-title":"Front Hum Neurosci"},{"issue":"3","key":"7506_CR160","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1017\/S0033291723003148","volume":"54","author":"TA Kuut","year":"2024","unstructured":"Kuut TA, Buffart LM, Braamse AMJ, Csorba I, Bleijenberg G, Nieuwkerk P, et al. Does the effect of cognitive behavior therapy for chronic fatigue syndrome (ME\/CFS) vary by patient characteristics? A systematic review and individual patient data meta-analysis. Psychol Med. 2024;54(3):447\u201356.","journal-title":"Psychol Med"},{"issue":"8","key":"7506_CR161","doi-asserted-by":"publisher","first-page":"e24839","DOI":"10.2196\/24839","volume":"23","author":"E Albers","year":"2021","unstructured":"Albers E, Nijhof LN, van der Berkelbach EE, van de Putte EM, Nijhof SL, Knoop H. Effectiveness of Internet-Based cognitive behavior therapy (Fatigue in teenagers on the Internet) for adolescents with chronic fatigue syndrome in routine clinical care: observational study. J Med Internet Res. 2021;23(8):e24839.","journal-title":"J Med Internet Res"},{"issue":"6","key":"7506_CR162","doi-asserted-by":"publisher","first-page":"895","DOI":"10.1007\/s12529-023-10254-2","volume":"31","author":"F Maas Genannt Bermpohl","year":"2024","unstructured":"Maas Genannt Bermpohl F, Kucharczyk-Bodenburg AC, Martin A. Efficacy and acceptance of cognitive behavioral therapy in adults with chronic fatigue syndrome: A Meta-analysis. Int J Behav Med. 2024;31(6):895\u2013910.","journal-title":"Int J Behav Med"},{"issue":"8","key":"7506_CR163","doi-asserted-by":"publisher","first-page":"1735","DOI":"10.1017\/S0033291723003690","volume":"54","author":"ME van der Schaaf","year":"2024","unstructured":"van der Schaaf ME, Geerligs L, Toni I, Knoop H, Oosterman JM. Disentangling pain and fatigue in chronic fatigue syndrome: a resting state connectivity study before and after cognitive behavioral therapy. Psychol Med. 2024;54(8):1735\u201348.","journal-title":"Psychol Med"},{"issue":"2","key":"7506_CR164","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1007\/s11606-021-07188-4","volume":"37","author":"M Sharpe","year":"2022","unstructured":"Sharpe M, Chalder T, White PD. Evidence-Based care for people with chronic fatigue syndrome and myalgic encephalomyelitis. J Gen Intern Med. 2022;37(2):449\u201352.","journal-title":"J Gen Intern Med"},{"issue":"20","key":"7506_CR165","doi-asserted-by":"publisher","first-page":"5878","DOI":"10.1080\/09638288.2021.1949049","volume":"44","author":"A Smakowski","year":"2022","unstructured":"Smakowski A, Adamson J, Turner T, Chalder T. Graded exercise therapy for patients with chronic fatigue syndrome in secondary care - a benchmarking study. Disabil Rehabil. 2022;44(20):5878\u201386.","journal-title":"Disabil Rehabil"},{"issue":"14","key":"7506_CR166","doi-asserted-by":"publisher","first-page":"2917","DOI":"10.1017\/S0033291722002471","volume":"52","author":"T Ingman","year":"2022","unstructured":"Ingman T, Smakowski A, Goldsmith K, Chalder T. A systematic literature review of randomized controlled trials evaluating prognosis following treatment for adults with chronic fatigue syndrome. Psychol Med. 2022;52(14):2917\u201329.","journal-title":"Psychol Med"},{"key":"7506_CR167","doi-asserted-by":"crossref","unstructured":"Marks DF. Treatment harms to patients with myalgic encephalomyelitis\/chronic fatigue syndrome. Qeios. 2023.","DOI":"10.32388\/XUG3PT.2"},{"issue":"5","key":"7506_CR168","doi-asserted-by":"publisher","first-page":"2343","DOI":"10.1007\/s00431-024-05458-x","volume":"183","author":"DM Gaunt","year":"2024","unstructured":"Gaunt DM, Brigden A, Harris SRS, Hollingworth W, Jago R, Solomon-Moore E, et al. Graded exercise therapy compared to activity management for paediatric chronic fatigue syndrome\/myalgic encephalomyelitis: pragmatic randomized controlled trial. Eur J Pediatr. 2024;183(5):2343\u201351.","journal-title":"Eur J Pediatr"},{"issue":"5","key":"7506_CR169","first-page":"898","volume":"10","author":"M Vink","year":"2022","unstructured":"Vink M, Vink-Niese A. The updated NICE guidance exposed the serious flaws in CBT and graded exercise therapy trials for ME\/CFS. Healthc (Basel). 2022;10(5):898.","journal-title":"Healthc (Basel)"},{"issue":"4","key":"7506_CR170","doi-asserted-by":"publisher","first-page":"1","DOI":"10.15761\/MRI.1000118","volume":"1","author":"F Twisk","year":"2017","unstructured":"Twisk F. The effects of therapies for myalgic encephalomyelitis and chronic fatigue syndrome should be assessed using objective measures. Med Res Innov. 2017;1(4):1\u20134.","journal-title":"Med Res Innov"},{"key":"7506_CR171","doi-asserted-by":"publisher","first-page":"n2643","DOI":"10.1136\/bmj.n2643","volume":"375","author":"I Torjesen","year":"2021","unstructured":"Torjesen I. ME\/CFS: exercise goals should be set by patients and not driven by treatment plan, says NICE. BMJ. 2021;375:n2643.","journal-title":"BMJ"},{"key":"7506_CR172","unstructured":"NICE. Myalgic encephalomyelitis (or encephalopathy)\/chronic fatigue syndrome: diagnosis and management. 2021. Available from: https:\/\/www.nice.org.uk\/guidance\/ng206"},{"issue":"1","key":"7506_CR173","doi-asserted-by":"publisher","first-page":"720","DOI":"10.1186\/s12967-023-04587-5","volume":"21","author":"NEM Sanal-Hayes","year":"2023","unstructured":"Sanal-Hayes NEM, McLaughlin M, Hayes LD, Mair JL, Ormerod J, Carless D, et al. A scoping review of \u2018Pacing\u2019 for management of myalgic Encephalomyelitis\/Chronic fatigue syndrome (ME\/CFS): lessons learned for the long COVID pandemic. J Transl Med. 2023;21(1):720.","journal-title":"J Transl Med"},{"key":"7506_CR174","doi-asserted-by":"crossref","unstructured":"Homewood S, Hinkle CA, Kaklopoulou I. Cripping the co-design of pacing technologies for energy-limiting conditions. In CHI Conference on Human Factors in Computing Systems (CHI \u201925); Yokohama, Japan. 2025. pp. 1\u201316.","DOI":"10.1145\/3706598.3713990"},{"issue":"23","key":"7506_CR175","doi-asserted-by":"publisher","first-page":"3788","DOI":"10.1080\/09638288.2022.2135776","volume":"45","author":"S Casson","year":"2023","unstructured":"Casson S, Jones MD, Cassar J, Kwai N, Lloyd AR, Barry BK, et al. The effectiveness of activity pacing interventions for people with chronic fatigue syndrome: a systematic review and meta-analysis. Disabil Rehabil. 2023;45(23):3788\u2013802.","journal-title":"Disabil Rehabil"},{"key":"7506_CR176","doi-asserted-by":"publisher","first-page":"4715679","DOI":"10.1155\/2020\/4715679","volume":"2020","author":"X Zhang","year":"2020","unstructured":"Zhang X, Wang M, Zhou S. Advances in clinical research on traditional Chinese medicine treatment of chronic fatigue syndrome. Evid Based Complement Alternat Med. 2020;2020:4715679.","journal-title":"Evid Based Complement Alternat Med"},{"key":"7506_CR177","doi-asserted-by":"publisher","first-page":"813748","DOI":"10.3389\/fimmu.2021.813748","volume":"12","author":"JE Oh","year":"2021","unstructured":"Oh JE, Kim SN. Anti-Inflammatory effects of acupuncture at ST36 point: A literature review in animal studies. Front Immunol. 2021;12:813748.","journal-title":"Front Immunol"},{"key":"7506_CR178","doi-asserted-by":"publisher","first-page":"7191","DOI":"10.2147\/JIR.S341581","volume":"14","author":"N Li","year":"2021","unstructured":"Li N, Guo Y, Gong Y, Zhang Y, Fan W, Yao K, et al. The Anti-Inflammatory actions and mechanisms of acupuncture from acupoint to target organs via Neuro-Immune regulation. J Inflamm Res. 2021;14:7191\u2013224.","journal-title":"J Inflamm Res"},{"issue":"9","key":"7506_CR179","doi-asserted-by":"publisher","first-page":"e0271098","DOI":"10.1371\/journal.pone.0271098","volume":"17","author":"Y Zhao","year":"2022","unstructured":"Zhao Y, Zhou B, Zhang G, Xu S, Yang J, Deng S, et al. The effect of acupuncture on oxidative stress: A systematic review and meta-analysis of animal models. PLoS ONE. 2022;17(9):e0271098.","journal-title":"PLoS ONE"},{"issue":"1","key":"7506_CR180","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1186\/s13643-024-02463-x","volume":"13","author":"QN Bao","year":"2024","unstructured":"Bao QN, Xia MZ, Xiong J, Liu YW, Li YQ, Zhang XY, et al. The effect of acupuncture on oxidative stress in animal models of vascular dementia: a systematic review and meta-analysis. Syst Rev. 2024;13(1):59.","journal-title":"Syst Rev"},{"issue":"2","key":"7506_CR181","first-page":"242","volume":"42","author":"MA Tingting","year":"2022","unstructured":"Tingting MA, Jie WU, Lijie Y, Fen F, Huilin Y, Jinhua Z, et al. Ginger-indirect moxibustion plus acupuncture versus acupuncture alone for chronic fatigue syndrome: a randomized controlled trial. J Tradit Chin Med. 2022;42(2):242\u20139.","journal-title":"J Tradit Chin Med"},{"issue":"4","key":"7506_CR182","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1136\/acupmed-2017-011582","volume":"37","author":"Q Zhang","year":"2019","unstructured":"Zhang Q, Gong J, Dong H, Xu S, Wang W, Huang G. Acupuncture for chronic fatigue syndrome: a systematic review and meta-analysis. Acupunct Med. 2019;37(4):211\u201322.","journal-title":"Acupunct Med"},{"key":"7506_CR183","doi-asserted-by":"publisher","first-page":"153602","DOI":"10.1016\/j.phymed.2021.153602","volume":"88","author":"C Yin","year":"2021","unstructured":"Yin C, Fu X, Chou J, Li J, Chen Y, Bai J, et al. A proprietary herbal drug young yum pill ameliorates chronic fatigue syndrome in mice. Phytomedicine. 2021;88:153602.","journal-title":"Phytomedicine"},{"key":"7506_CR184","doi-asserted-by":"publisher","first-page":"155636","DOI":"10.1016\/j.phymed.2024.155636","volume":"129","author":"L Dai","year":"2024","unstructured":"Dai L, Liu Z, Zhou W, Zhang L, Miao M, Wang L, et al. Sijunzi decoction, a classical Chinese herbal formula, improves fatigue symptoms with changes in gut microbiota in chronic fatigue syndrome: A randomized, double-blind, placebo-controlled, multi-center clinical trial. Phytomedicine. 2024;129:155636.","journal-title":"Phytomedicine"},{"key":"7506_CR185","doi-asserted-by":"publisher","first-page":"1496774","DOI":"10.3389\/fphar.2025.1496774","volume":"16","author":"Q Wang","year":"2025","unstructured":"Wang Q, Zhou J, Gong G. Efficacy and safety of Xiaoyao San in the treatment of chronic fatigue syndrome: a systematic review and meta-analysis. Front Pharmacol. 2025;16:1496774.","journal-title":"Front Pharmacol"},{"issue":"1","key":"7506_CR186","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1186\/s12955-022-02082-x","volume":"20","author":"H Naik","year":"2022","unstructured":"Naik H, Shao S, Tran KC, Wong AW, Russell JA, Khor E, et al. Evaluating fatigue in patients recovering from COVID-19: validation of the fatigue severity scale and single item screening questions. Health Qual Life Outcomes. 2022;20(1):170.","journal-title":"Health Qual Life Outcomes"},{"key":"7506_CR187","first-page":"217","volume":"12","author":"P Gladwell","year":"2024","unstructured":"Gladwell P, Harland M, Adrissi A, Kershaw S, Dures E. Exploring the content validity of the Chalder fatigue scale using cognitive interviewing in an ME\/CFS population. Fatigue: Biomed Health Behav. 2024;12:217\u201337.","journal-title":"Fatigue: Biomed Health Behav"},{"issue":"1","key":"7506_CR188","doi-asserted-by":"publisher","first-page":"53","DOI":"10.37526\/1526-744X.2025.52.1.53","volume":"52","author":"B Joshwa","year":"2025","unstructured":"Joshwa B, Zimmerman RS, Yarandi HN, Malek MH, Campbell M. Psychometric properties of Patient-Reported outcomes measurement information systems (PROMIS) computer adaptive test (CAT) - Fatigue in individuals receiving chronic Hemodialysis therapy: A secondary analysis. Nephrol Nurs J. 2025;52(1):53\u201365.","journal-title":"Nephrol Nurs J"},{"issue":"1","key":"7506_CR189","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1053\/j.ajkd.2022.12.018","volume":"82","author":"S Dano","year":"2023","unstructured":"Dano S, Hussain J, Edwards N, Sun YI, Li M, Howell D, et al. Assessing fatigue in patients receiving kidney replacement therapy using PROMIS computer adaptive testing. Am J Kidney Dis. 2023;82(1):33\u201342.e1.","journal-title":"Am J Kidney Dis"},{"issue":"2","key":"7506_CR190","doi-asserted-by":"publisher","first-page":"EVIDra2400390","DOI":"10.1056\/EVIDra2400390","volume":"4","author":"TL Brazile","year":"2025","unstructured":"Brazile TL, Levine BD, Shafer KM. Cardiopulmonary exercise testing. NEJM Evid. 2025;4(2):EVIDra2400390.","journal-title":"NEJM Evid"},{"key":"7506_CR191","doi-asserted-by":"crossref","unstructured":"Zli\u010di\u0107 T, \u0160\u0107epanovi\u0107 T, Milovanovi\u0107 I, Korovljev D. Effects of graded exercise therapy and medical care on chronic fatigue syndrome. Ann Kinesiologiae. 2024;14(2):143\u2013154.","DOI":"10.35469\/ak.2023.425"},{"issue":"4","key":"7506_CR192","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1515\/reveh-2015-0026","volume":"30","author":"AC Bested","year":"2015","unstructured":"Bested AC, Marshall LM. Review of myalgic Encephalomyelitis\/Chronic fatigue syndrome: an evidence-based approach to diagnosis and management by clinicians. Rev Environ Health. 2015;30(4):223\u201349.","journal-title":"Rev Environ Health"},{"issue":"1","key":"7506_CR193","doi-asserted-by":"publisher","first-page":"1538","DOI":"10.1038\/s41598-024-51379-y","volume":"14","author":"MR Shadzi","year":"2024","unstructured":"Shadzi MR, Rahmanian M, Heydari A, Salehi A. Structural validity of the Pittsburgh sleep quality index among medical students in Iran. Sci Rep. 2024;14(1):1538.","journal-title":"Sci Rep"},{"issue":"5","key":"7506_CR194","first-page":"780","volume":"61","author":"T Vanagas","year":"2025","unstructured":"Vanagas T, Lipskyt\u0117 D, Tamo\u0161i\u016bnait\u0117 J, Petrikonis K, Paj\u0117dien\u0117 E. Can we reduce the diagnostic burden of sleep disorders? A Single-Centre study of subjective and objective sleep-Related diagnostic parameters. Med (Kaunas). 2025;61(5):780.","journal-title":"Med (Kaunas)"},{"issue":"1","key":"7506_CR195","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1111\/bjhp.12136","volume":"21","author":"ZM Gotts","year":"2016","unstructured":"Gotts ZM, Newton JL, Ellis JG, Deary V. The experience of sleep in chronic fatigue syndrome: A qualitative interview study with patients. Br J Health Psychol. 2016;21(1):71\u201392.","journal-title":"Br J Health Psychol"},{"key":"7506_CR196","doi-asserted-by":"publisher","first-page":"101597","DOI":"10.1016\/j.smrv.2022.101597","volume":"62","author":"E Hertenstein","year":"2022","unstructured":"Hertenstein E, Trinca E, Wunderlin M, Schneider CL, Z\u00fcst MA, Feh\u00e9r KD, et al. Cognitive behavioral therapy for insomnia in patients with mental disorders and comorbid insomnia: A systematic review and meta-analysis. Sleep Med Rev. 2022;62:101597.","journal-title":"Sleep Med Rev"},{"key":"7506_CR197","doi-asserted-by":"publisher","first-page":"121","DOI":"10.3389\/fped.2017.00121","volume":"5","author":"PC Rowe","year":"2017","unstructured":"Rowe PC, Underhill RA, Friedman KJ, Gurwitt A, Medow MS, Schwartz MS, et al. Myalgic Encephalomyelitis\/Chronic fatigue syndrome diagnosis and management in young people: A primer. Front Pediatr. 2017;5:121.","journal-title":"Front Pediatr"},{"issue":"1","key":"7506_CR198","doi-asserted-by":"publisher","first-page":"2157","DOI":"10.1038\/s41598-021-04764-w","volume":"12","author":"M Aoun Sebaiti","year":"2022","unstructured":"Aoun Sebaiti M, Hainselin M, Gounden Y, Sirbu CA, Sekulic S, Lorusso L, et al. Systematic review and meta-analysis of cognitive impairment in myalgic encephalomyelitis\/chronic fatigue syndrome (ME\/CFS). Sci Rep. 2022;12(1):2157.","journal-title":"Sci Rep"},{"issue":"4","key":"7506_CR199","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1007\/s10286-019-00615-x","volume":"29","author":"J Kemp","year":"2019","unstructured":"Kemp J, Sunnquist M, Jason LA, Newton JL. Autonomic dysfunction in myalgic encephalomyelitis and chronic fatigue syndrome: comparing self-report and objective measures. Clin Auton Res. 2019;29(4):475\u20137.","journal-title":"Clin Auton Res"},{"issue":"1","key":"7506_CR200","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/pathophysiology31010001","volume":"31","author":"VA Ryabkova","year":"2024","unstructured":"Ryabkova VA, Rubinskiy AV, Marchenko VN, Trofimov VI, Churilov LP. Similar patterns of Dysautonomia in myalgic Encephalomyelitis\/Chronic fatigue and Post-COVID-19 syndromes. Pathophysiology. 2024;31(1):1\u201317.","journal-title":"Pathophysiology"},{"issue":"3","key":"7506_CR201","doi-asserted-by":"publisher","first-page":"238","DOI":"10.3390\/jpm14030238","volume":"14","author":"LA Jason","year":"2024","unstructured":"Jason LA, McGarrigle WJ, Vermeulen RCW. The Head-Up Tilt table test as a measure of autonomic functioning among patients with myalgic Encephalomyelitis\/Chronic fatigue syndrome. J Pers Med. 2024;14(3):238.","journal-title":"J Pers Med"},{"issue":"1","key":"7506_CR202","doi-asserted-by":"publisher","first-page":"e14318","DOI":"10.1111\/eci.14318","volume":"55","author":"J Hendrix","year":"2025","unstructured":"Hendrix J, Fanning L, Wyns A, Ahmed I, Patil MS, Richter E, et al. Adrenergic dysfunction in patients with myalgic encephalomyelitis\/chronic fatigue syndrome and fibromyalgia: A systematic review and meta-analysis. Eur J Clin Invest. 2025;55(1):e14318.","journal-title":"Eur J Clin Invest"},{"issue":"Supplement1","key":"7506_CR203","first-page":"229","volume":"210","author":"M Hanson","year":"2023","unstructured":"Hanson M, Maya J. Investigating T cell populations for immune cell exhaustion in myalgic encephalomyelitis\/chronic fatigue syndrome. J Immunol. 2023;210(Supplement1):229\u201301.","journal-title":"J Immunol"},{"issue":"1Supplement","key":"7506_CR204","first-page":"10755069","volume":"212","author":"M Hanson","year":"2024","unstructured":"Hanson M, Grenier J, Maya J, Iu D, Munn P, Fogarty E, et al. Epigenetic reprogramming of CD8\u2009+\u2009T cell populations drives exhaustion in myalgic Encephalomyelitis\/Chronic fatigue syndrome (ME\/CFS). J Immunol. 2024;212(1Supplement):10755069.","journal-title":"J Immunol"},{"issue":"2","key":"7506_CR205","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1016\/j.chom.2023.01.004","volume":"31","author":"C Guo","year":"2023","unstructured":"Guo C, Che X, Briese T, Ranjan A, Allicock O, Yates RA, et al. Deficient butyrate-producing capacity in the gut Microbiome is associated with bacterial network disturbances and fatigue symptoms in ME\/CFS. Cell Host Microbe. 2023;31(2):288\u2013e3048.","journal-title":"Cell Host Microbe"},{"issue":"21","key":"7506_CR206","doi-asserted-by":"publisher","first-page":"5077","DOI":"10.3390\/jcm10215077","volume":"10","author":"A Varesi","year":"2021","unstructured":"Varesi A, Deumer US, Ananth S, Ricevuti G. The emerging role of gut microbiota in myalgic Encephalomyelitis\/Chronic fatigue syndrome (ME\/CFS): current evidence and potential therapeutic applications. J Clin Med. 2021;10(21):5077.","journal-title":"J Clin Med"},{"issue":"20","key":"7506_CR207","first-page":"2020","volume":"12","author":"H Fricke-Comellas","year":"2024","unstructured":"Fricke-Comellas H, Heredia-Rizo AM, Casuso-Holgado MJ, Salas-Gonz\u00e1lez J, Fern\u00e1ndez-Segu\u00edn LM. Exploring the effects of Qigong, Tai Chi, and yoga on fatigue, mental Health, and sleep quality in chronic fatigue and Post-COVID syndromes: A systematic review with Meta-Analysis. Healthc (Basel). 2024;12(20):2020.","journal-title":"Healthc (Basel)"},{"issue":"4","key":"7506_CR208","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1089\/acm.2014.0055","volume":"21","author":"RK Yadav","year":"2015","unstructured":"Yadav RK, Sarvottam K, Magan D, Yadav R. A two-year follow-up case of chronic fatigue syndrome: substantial improvement in personality following a yoga-based lifestyle intervention. J Altern Complement Med. 2015;21(4):246\u20139.","journal-title":"J Altern Complement Med"},{"key":"7506_CR209","doi-asserted-by":"crossref","unstructured":"Tran HH, Thu A, Fuertes A, Radha Twayan A, Mehta KA, Basta M, et al. Noninvasive vagal nerve stimulation for the treatment of postural orthostatic tachycardia syndrome: a comprehensive review. Cardiol Rev. 2025.","DOI":"10.1097\/CRD.0000000000000953"},{"key":"7506_CR210","doi-asserted-by":"publisher","first-page":"e46992","DOI":"10.2196\/46992","volume":"25","author":"E Pyper","year":"2023","unstructured":"Pyper E, McKeown S, Hartmann-Boyce J, Powell J. Digital health technology for Real-World clinical outcome measurement using Patient-Generated data: systematic scoping review. J Med Internet Res. 2023;25:e46992.","journal-title":"J Med Internet Res"},{"issue":"1","key":"7506_CR211","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1038\/s41746-023-00841-8","volume":"6","author":"M Mittermaier","year":"2023","unstructured":"Mittermaier M, Venkatesh KP, Kvedar JC. Digital health technology in clinical trials. NPJ Digit Med. 2023;6(1):88.","journal-title":"NPJ Digit Med"}],"container-title":["Journal of Translational Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-025-07506-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12967-025-07506-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-025-07506-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,14]],"date-time":"2026-01-14T04:54:59Z","timestamp":1768366499000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12967-025-07506-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,9]]},"references-count":211,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["7506"],"URL":"https:\/\/doi.org\/10.1186\/s12967-025-07506-y","relation":{},"ISSN":["1479-5876"],"issn-type":[{"value":"1479-5876","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,9]]},"assertion":[{"value":"9 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 November 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 December 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"62"}}